Trials / Completed
CompletedNCT02910440
A Safety and Efficacy Study of DCL-101 Compared to GoLYTELY
A Randomized, Investigator-blinded, Non-inferiority, Multicenter Study Evaluating the Safety and Efficacy of DCL-101 Compared to GoLYTELY in Adult Outpatients Undergoing Routine Colonoscopy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Dark Canyon Laboratories, LLC · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this Phase 2 Study was to compare the safety of 3 liter(L) and 4 liter(L) split dose DCL-101 to split dose 4L GoLYTELY in patients preparing for colonoscopy, with secondary objectives to assess tolerability and bowel cleansing efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DCL-101 vs Golytely |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2016-09-22
- Last updated
- 2020-05-13
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02910440. Inclusion in this directory is not an endorsement.